Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

University of Victoria

$54,500.00

Using Metallic Nanostructures to Develop Biomedical Devices for Newborn Screening

EF 2023-24

Résumé
Newborn screening (NSB) is a preventative action aiming to diagnose genetic, metabolic, enzymatic, or hormonal diseases, preferably between the third and fifth day of life of the child. The implementation of NSB since the 60's has saved thousands of lives and this procedure is now routine in most of North America. However, 2/3 of the newborns worldwide are not submitted to any type of NSB. The main limitation for the implementation of NSB in low resources settings is related to the access of basic infrastructure for the processing of clinical samples (typically, blood samples obtained through the heel-prick method). This international collaboration proposes to explore distinct technical routes to develop a new set of nanostructured materials for biosensing applications. The goal is to take advantage of the specific optical properties of the materials to assemble miniaturized biosensors for rapid tests in low resources environment. The goal is to obtain portable devices or biosensors capable of performing specific measurements in biological fluids and to estimate the status of diseases that are important for NSB, such as phenylketonuria, cystic fibrosis, and G6PD deficiency, in real time. The devices will be compared to commercially available tests and, if they reach appropriate values of specificity and sensitivity, they will be evaluated with real newborn samples by our collaborators in Brazil. The success of the present proposal will provide a new set of materials and tools that will increase the access of NSB in areas of low resources (rural/isolated areas in Canada and developing Countries).
Programme
Alliance Grants
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
571868-2021
Name nom
Brolo, Alexandre AGB
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
54500
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3505
Research subject group en
Analytical chemistry
Research subject group fr
Analytical spectroscopy
Research subject en
Chimie analytique
Research subject fr
Spectroscopie analytique
Application title
Using Metallic Nanostructures to Develop Biomedical Devices for Newborn Screening
Keyword
biosensors; heel-prick test; Immunoassay; metallic nanostructures; Nanotechnology; newborn screening; plasmonics; Rapid test; surface-enhanced Raman scattering; surface plasmon resonance
Application summary
Newborn screening (NSB) is a preventative action aiming to diagnose genetic, metabolic, enzymatic, or hormonal diseases, preferably between the third and fifth day of life of the child. The implementation of NSB since the 60's has saved thousands of lives and this procedure is now routine in most of North America. However, 2/3 of the newborns worldwide are not submitted to any type of NSB. The main limitation for the implementation of NSB in low resources settings is related to the access of basic infrastructure for the processing of clinical samples (typically, blood samples obtained through the heel-prick method). This international collaboration proposes to explore distinct technical routes to develop a new set of nanostructured materials for biosensing applications. The goal is to take advantage of the specific optical properties of the materials to assemble miniaturized biosensors for rapid tests in low resources environment. The goal is to obtain portable devices or biosensors capable of performing specific measurements in biological fluids and to estimate the status of diseases that are important for NSB, such as phenylketonuria, cystic fibrosis, and G6PD deficiency, in real time. The devices will be compared to commercially available tests and, if they reach appropriate values of specificity and sensitivity, they will be evaluated with real newborn samples by our collaborators in Brazil. The success of the present proposal will provide a new set of materials and tools that will increase the access of NSB in areas of low resources (rural/isolated areas in Canada and developing Countries).